Accelerating innovation through genetically engineered mouse models and preclinical solutions. GemPharmatech is a leading contract research organization that provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. Our company is steadfast in its commitment to providing cutting-edge and novel solutions to researchers in their pursuit of scientific exploration and pharmaceutical development. At GemPharmatech, we specialize in the development of animal models utilizing advanced gene-editing technologies, and we have an extensive library of KO/cKO mice, humanized mice, immunodeficient mice, and germ-free mice. We offer a wide range of preclinical services, including mouse model customization, pharmacology services such as drug efficacy evaluation and mouse phenotyping, CRISPR/Cas9 gene editing, cryopreservation, and customized breeding. Our ultimate goal is to accelerate scientific advancement and pharmaceutical development by supporting our clients with the most innovative tools and services. By partnering with GemPharmatech, our clients benefit from having access to a comprehensive range of research tools and services to aid them in their research endeavors and promote scientific discovery. GemPharmatech is committed to pushing the boundaries of preclinical research and assisting our customers in achieving their research ambitions.
Nanjing City, China
Founded in 2017
501-1000 Employees
Medium-Sized
Working industry
Biotechnology
Type of company
Service provider, Manufacturer
Ownership structure
Privately Held
Locations
2 Locations
Number of products
16 Products
Specialised areas
Biotechnology, 生物医药, 生物科技, 动物模型
GemPharmatech offers a wide range of products and services
Product
Rnf10-KO|Strain NO.T011470
Go to product >
Product
Olfr520-flox|Strain NO.T006385
Go to product >
Product
Srebf2-flox|Strain NO.T015077
Go to product >
Product
Cmip-flox|Strain NO.T008599
Go to product >
Product
Sppl2c-flox|Strain NO.T025231
Go to product >
Product
Sulf2-flox|Strain NO.T026442
Go to product >
Product
Cks1b-KO|Strain NO.T028256
Go to product >
Product
Tnrc6a-flox|Strain NO.T024078
Go to product >
An estimation about the ESG values based on digital data and signals. Important: The ESG scores are only based on information about the country, not the actual company itself
Country:
China
Overall risk estimation:
High
The ESG Data of countries are based on public sources
Environment
E
Grade (A-E)
View details
Social
C
Grade (A-E)
View details
Governance
E
Grade (A-E)
View details
GemPharmatech operates in 2 countries around the world
Get an overview of the locations of GemPharmatech
Location
Country
State
City
Headquarter
China
Jiangsu
Nanjing City
U.S. subsidiary
United States
Delaware
Wilmington
Some frequent questions that have been asked about GemPharmatech
Where is GemPharmatech located?
The company headquarter of GemPharmatech is located in Nanjing City, Jiangsu, China. GemPharmatech has subsidiaries in United States
How many employees does GemPharmatech approximately have?
As of the latest available information GemPharmatech has around 501-1000 employees worldwide.
When was GemPharmatech founded?
GemPharmatech was founded in 2017
In which industries does GemPharmatech mainly work?
The company GemPharmatech has it's main focus in the industries of Biotechnology
What is the current company status of GemPharmatech?
Based on the founding year and the amount of employees the company GemPharmatech seems to be a Medium-Sized at the current state. Note that over time that status can change
Check out some interesting alternative companies to GemPharmatech
BIOMEDCODE HELLAS S.A.
Vari, Greece
11-50 Employees
2006
Biomedcode is a Contract Research Organization (CRO) specialized in Preclinical Testing. We are experts in the development of mouse models of human pathologies as specialized tools for the efficient evaluation of human therapeutics and we offer a unique collection of disease models humanized for specific therapeutic targets. Biomedcode was founded in 2006 as a spin-off company of the Biomedical Sciences Research Center “Alexander Fleming”. We offer specialized preclinical testing using unique humanized transgenic mouse models mimicking human diseases. We offer Preclinical Services Customized to your Needs. Our extended portfolio of unique mouse disease models, together with our long-lasting expertise in preclinical testing, our standardized procedures as well as the customer oriented scientific consultation and services we provide, constitute our unmatched competitive advantage. Our resources include a team of highly educated and experienced scientists and technicians that operate in our SPF research animal facility and state-of-the-art laboratory. We offer expert solutions for optimal preclinical testing.
Genemedi Biotech
Shanghai, China
11-50 Employees
2012
GeneMedi Vision : Curiosity & Creativity to Improve Human Health. We develop solutions for the therapeutics and diagnostics industry. GTU empowers self-capabilities for application development to develop more powerful products and solutions to meet the needs of the biologics industry. GTU & G-NEXT combine the novel AAV rational design, smart discovery and State-of-the-Art manufacturing to meet the industrial unmet for next generation of gene therapy. Membrane Protein & antibodies artificail design, discovery and State-of-the-Art Manufacturing. High quality, scalable, State-of-the-Art Manufacturing in gene therapy vectors including adenoassociated virus (AAV) vector, lentivirus vector and adenovirus vector.
GenX l Fraxa-DVI
London, United Kingdom
11-50 Employees
2017
Our mission is to provide the best validated disease models and comprehensive preclinical capabilities with an innovative drug screening technology and a development-stage drug candidate.Through our 10+ years of experience, our team of talented scientists have developed innovative AI-driven drug discovery platforms and analytical tools leading to partnerships and numerous drug candidates in clinical trials. GeN is a drug discovery and pre-clinical validation company with expertise in CNS and orphan disorders.
GEMFORLAB - ABLE Biosciences
Caluso, Italy
1-10 Employees
2011
We are committed to converting each project engagement into a long-term relationship. Our services are aimed at solving problems related to the quality, safety and effectiveness of compounds undergoing development. It delivers solutions to companies of any size in compliance with GLP and GCP principles. ABLE Biosciences is a GLP certified Test Facility for quantitative analysis of small and large molecules in biological matrices by means of mass spectrometry, immunometric assays and qPCR. We strive to achieve our mission through delivering customized, high-quality results and providing added value services beyond customers’ expectations. GEM FORLAB is the partner of choice for small companies, R&D centers and multinational corporations which require customized solutions to manage and solve R&D issues following regulatory requirements. GEM FORLAB as an R&D service provider is able to support companies in every phase of the pharmaceutical and biotechnological process, according to regulatory requirements. GEM FORLAB offers three main platforms, integrated with each other to deliver tailored solutions to our sponsors.
PolyGene AG
Rümlang, Switzerland
11-50 Employees
2002
PolyGene has a strong IP portfolio, including patent rights on innovative antibiotic-inducible expression systems, used exclusively for transgenic service projects. PolyGene offers the complete range of gene targeting and transgenic model generation in mouse, rat and rabbit. PolyGene is an innovative partner for large-scale scientific projects. Stay tuned for high-impact publications citing PolyGene mice, special offers, upcoming conferences and events. Providing premium cell culture and genotyping products to guarantee continued success in your molecular research institute.
Transpharmation
Dublin, Ireland
11-50 Employees
2010
As a leading preclinical contract research organisation (CRO), our suite of robust animal models and expertise in drug development research help advance your programs by offering reliable and clinically relevant data. From gold standard models to innovative customized platforms, our research services deliver the critical pieces of information needed to realize the full potential of your preclinical assets.